Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1386]
News [2583]
Articles [24]
Editorials [0]
Conferences [149]
elearning [15]
Nivolumab ipilimumab combo does not improve DFS for RCC after nephrectomy
Dr Robert Motzer - Memorial Sloan Kettering Cancer Center, New York, USA
Nivolumab ipilimumab combo does not improve DFS for RCC after nephrectomy ( Dr Robert Motzer - Memorial Sloan Kettering Cancer Center, New York, USA )
11 Sep 2022
Pembro + CRT in HNSCC fails to deliver statistically significant event-free...
Prof Jean-Pascal Machiels - Cliniques Universitaires Sain-Luc, Brussels, Belgium
Pembro + CRT in HNSCC fails to deliver statistically significant event-free survival improvement ( Prof Jean-Pascal Machiels - Cliniques Universitaires Sain-Luc, Brussels, Belgium )
11 Sep 2022
New era of early cancer detection blood tests on the horizon
Dr Deborah Schrag - Memorial Sloan Kettering Cancer Center, New York City, USA
New era of early cancer detection blood tests on the horizon ( Dr Deborah Schrag - Memorial Sloan Kettering Cancer Center, New York City, USA )
11 Sep 2022
Hyperthermic intraperitoneal chemo for locally advanced colon cancer
Dr Álvaro Arjona-Sánchez- Reina Sofia University Hospital, Cordoba, Spain
Hyperthermic intraperitoneal chemo for locally advanced colon cancer ( Dr Álvaro Arjona-Sánchez- Reina Sofia University Hospital, Cordoba, Spain )
11 Sep 2022
HER2-low mBC patients report preserved QOL with trastuzumab deruxtecan
Prof Naoto Ueno - The University of Texas MD Anderson Cancer Center, Houston...
HER2-low mBC patients report preserved QOL with trastuzumab deruxtecan ( Prof Naoto Ueno - The University of Texas MD Anderson Cancer Center, Houston, USA )
11 Sep 2022
Extended adjuvant AI not advised for HPBC after 5+ yrs of sequential endocrine...
Dr Vivianne Tjan-Heijnen - Maastricht University Medical Center, Maastricht...
Extended adjuvant AI not advised for HPBC after 5+ yrs of sequential endocrine therapy ( Dr Vivianne Tjan-Heijnen - Maastricht University Medical Center, Maastricht, Netherlands )
11 Sep 2022
Prognostic model of all-cause mortality at 30 days in patients with cancer and...
Dr Chris Labaki - Dana-Farber Cancer Institute, Boston, USA
Prognostic model of all-cause mortality at 30 days in patients with cancer and COVID-19 ( Dr Chris Labaki - Dana-Farber Cancer Institute, Boston, USA )
11 Sep 2022
New data presented at ESMO for multi-cancer early detection
Dr Tom Beer - Vice President and Chief Medical Officer of Exact Sciences
New data presented at ESMO for multi-cancer early detection ( Dr Tom Beer - Vice President and Chief Medical Officer of Exact Sciences )
10 Sep 2022
Olaparib continues to show positive results in advanced ovarian cancer - 7 year...
Prof Paul DiSilvestro - Women & Infants Hospital, Providence, USA
Olaparib continues to show positive results in advanced ovarian cancer - 7 year data ( Prof Paul DiSilvestro - Women & Infants Hospital, Providence, USA )
10 Sep 2022
How air pollution may trigger lung cancer in never-smokers
Prof Charles Swanton - Francis Crick Institute, London, England
How air pollution may trigger lung cancer in never-smokers ( Prof Charles Swanton - Francis Crick Institute, London, England )
10 Sep 2022
Tumour-infiltrating lymphocyte treatment for advanced melanoma
Dr John Haanen - Netherlands Cancer Institute, Amsterdam, Netherlands
Tumour-infiltrating lymphocyte treatment for advanced melanoma ( Dr John Haanen - Netherlands Cancer Institute, Amsterdam, Netherlands )
10 Sep 2022
Nirogacestat success for desmoid tumours
Dr Bernd Kasper - Universitätsmedizin Mannheim, Mannheim, Germany
Nirogacestat success for desmoid tumours ( Dr Bernd Kasper - Universitätsmedizin Mannheim, Mannheim, Germany )
10 Sep 2022

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation